Cellceutix Corporation
100 Cumming Center
Suite 151-B
Beverly,
MA 01915
United States - Map
Phone: 978-633-3623
| Cellceutix Corporation, a development stage biopharmaceutical company, develops cancer and anti-inflammatory drugs in the United States. The companys lead product candidate includes Kevetrin, which is in pre-clinical development stage primarily for the treatment of head and neck cancers. It is also developing various other product candidates for the treatment of psoriasis, rheumatoid arthritis, osteo-arthritis/asthma, and hypertensive emergency, as well as neurological disorders, such as multiple sclerosis, Lou Gehrig disease, and/or Parkinson's disease. The company was founded in 2007 and is headquartered in Beverly, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. George W. Evans J.D., M.B.A, 55
Chairman and Chief Exec. Officer |
$
258.00K | N/A | Dr. Krishna Menon RCM, Ph.D., VMD, 63
Pres, Chief Scientific Officer |
$
258.00K | N/A | Mr. Leo Ehrlich CPA, 51
Chief Financial Officer |
$
200.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.02% Nasdaq 
0.19%
Profile
